Search

everythinglearnresearchcommunity

for

Search:↓

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

Testosterone may both worsen and protect against COVID-19 effects in men.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Melatonin improved cashmere production in goats during the first cycle but had no lasting effects on the next cycle.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

A woman's excessive hair growth was caused by a rare benign tumor in her adrenal gland, which was successfully removed.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.